SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 29.93 |
| Enterprise Value ($M) | 10.86 |
| Book Value ($M) | 83.37 |
| Book Value / Share | 5.74 |
| Price / Book | 0.36 |
| NCAV ($M) | 81.92 |
| NCAV / Share | 5.64 |
| Price / NCAV | 0.37 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -0.35 |
| Return on Assets (ROA) | -1.17 |
| Return on Equity (ROE) | -1.68 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 13.02 |
| Current Ratio | 13.02 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 90.22 |
| Assets | 91.68 |
| Liabilities | 8.31 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.42 |
| Operating Income | -29.26 |
| Net Income | -28.45 |
| Earnings Per Share Basic And Diluted | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | -25.34 |
| Cash from Investing | -57.35 |
| Cash from Financing | 82.39 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G/A | Citadel Advisors Llc | 8.50 | ||
| 13G/A | Soleus Capital Master Fund, L.P. | 5.00 | -20.99 | |
| 13D | AI Biotechnology LLC | 19.99 | ||
| 13G | Cormorant Asset Management, LP | 9.99 | ||
| 13G | Eventide Asset Management, Llc | 9.99 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 626 | 12,450 | 5.03 | |
| 1,368 | 15,229 | 8.98 | |
| 3,208 | 13,375 | 23.99 | |
| 4,644 | 46,904 | 9.90 | |
| 2,470 | 11,530 | 21.42 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| VTGN – Vistagen Therapeutics, Inc. | VTVT – vTv Therapeutics Inc. |
| VXRT – Vaxart, Inc. | WINT – Windtree Therapeutics, Inc. |
| XBIO – Xenetic Biosciences, Inc. |
Financial data and stock pages provided by
Fintel.io